Anti-mIDH1 monoclonal antibody

Pre-made anti-mIDH1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to mIDH1/IDH1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T88569-Ab-1/ GM-Tg-hg-T88569-Ab-2Anti-Human mIDH1/IDH1 monoclonal antibodyHuman
GM-Tg-rg-T88569-Ab-1/ GM-Tg-rg-T88569-Ab-2Anti-Rat mIDH1/IDH1 monoclonal antibodyRat
GM-Tg-mg-T88569-Ab-1/ GM-Tg-mg-T88569-Ab-2Anti-Mouse mIDH1/IDH1 monoclonal antibodyMouse
GM-Tg-cynog-T88569-Ab-1/ GM-Tg-cynog-T88569-Ab-2Anti-Cynomolgus/ Rhesus macaque mIDH1/IDH1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T88569-Ab-1/ GM-Tg-felg-T88569-Ab-2Anti-Feline mIDH1/IDH1 monoclonal antibodyFeline
GM-Tg-cang-T88569-Ab-1/ GM-Tg-cang-T88569-Ab-2Anti-Canine mIDH1/IDH1 monoclonal antibodyCanine
GM-Tg-bovg-T88569-Ab-1/ GM-Tg-bovg-T88569-Ab-2Anti-Bovine mIDH1/IDH1 monoclonal antibodyBovine
GM-Tg-equg-T88569-Ab-1/ GM-Tg-equg-T88569-Ab-2Anti-Equine mIDH1/IDH1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T88569-Ab-1/ GM-Tg-hg-T88569-Ab-2; GM-Tg-rg-T88569-Ab-1/ GM-Tg-rg-T88569-Ab-2;
GM-Tg-mg-T88569-Ab-1/ GM-Tg-mg-T88569-Ab-2; GM-Tg-cynog-T88569-Ab-1/ GM-Tg-cynog-T88569-Ab-2;
GM-Tg-felg-T88569-Ab-1/ GM-Tg-felg-T88569-Ab-2; GM-Tg-cang-T88569-Ab-1/ GM-Tg-cang-T88569-Ab-2;
GM-Tg-bovg-T88569-Ab-1/ GM-Tg-bovg-T88569-Ab-2; GM-Tg-equg-T88569-Ab-1/ GM-Tg-equg-T88569-Ab-2
Products NameAnti-mIDH1/IDH1 monoclonal antibody
Formatmab
Target NamemIDH1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-mIDH1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T88569-Ag-1Recombinant multi-species IDHC/ mIDH1/ IDH1 protein
    ORF Viral VectorvGMLV000343human IDH1 Lentivirus particle
    ORF Viral VectorpGMAD000601human IDH1 Adenovirus plasmid
    ORF Viral VectorpGMLV000345human IDH1 Lentivirus plasmid
    ORF Viral VectorpGMLV000644human IDH1 Lentivirus plasmid
    ORF Viral VectorpGMLV000344human IDH1 Lentivirus plasmid
    ORF Viral VectorvGMLV000644human IDH1 Lentivirus particle
    ORF Viral VectorvGMLV000345human IDH1 Lentivirus particle
    ORF Viral VectorpGMLV000343human IDH1 Lentivirus plasmid
    ORF Viral VectorvGMLV000344human IDH1 Lentivirus particle
    ORF Viral VectorvGMAD000601human IDH1 Adenovirus particle
    ORF Viral VectorpGMLPm001512mouse Idh1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001512mouse Idh1 Lentivirus particle


    Target information

    Target IDGM-T88569
    Target NamemIDH1
    Gene ID3417,15926,24479,710019,478889,751618,281235,100066416
    Gene Symbol and SynonymsE030024J03Rik,HEL-216,HEL-S-26,Id-1,IDCD,IDH,Idh-1,IDH1,IDP,IDPC,PICD
    Uniprot AccessionO75874,P41562,Q9XSG3
    Uniprot Entry NameIDHC_HUMAN,IDHC_RAT,IDHC_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseOvary Cancer
    Gene EnsemblENSG00000138413
    Target ClassificationN/A

    The target: mIDH1, gene name: IDH1, also named as HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC, PICD. Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the cytoplasm and peroxisomes. It contains the PTS-1 peroxisomal targeting signal sequence. The presence of this enzyme in peroxisomes suggests roles in the regeneration of NADPH for intraperoxisomal reductions, such as the conversion of 2, 4-dienoyl-CoAs to 3-enoyl-CoAs, as well as in peroxisomal reactions that consume 2-oxoglutarate, namely the alpha-hydroxylation of phytanic acid. The cytoplasmic enzyme serves a significant role in cytoplasmic NADPH production. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Sep 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.